3 completed. 3 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Completed 3 |
| Phase 3 | 1 | Completed 1 |
Follow Menactra: new trials by email Literature Review of Menactra trials Research Report on Menactra
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Lot to Lot Consistency of SIIPL Meningococcal ACYWX Conjugate Vaccine and to Compare Its Safety and Immunogenicity With That of Licensed Meningococcal ACWY Vaccine Menactra® in Healthy Individuals 18-85 Years of Age NmCV-5, Menactra - Vaccine for Meningococcal Disease | Phase 2 / Phase 3 | Completed | Serum Institute of India Pvt. Ltd. | 1640 | 2019-12-27 | 2021-09-08 |
| Pfs230D1M-EPA/AS01 Vaccine, a Transmission Blocking Vaccine Against Plasmodium Falciparum, in an Age De-Escalation Trial of Children and a Family Compound Trial in Mali Pfs230D1M-EPA/AS01, HAVRIX, TYPHIM Vi (Salmonella typhi vaccine) - Malaria | Phase 2 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 1301 | 2019-04-24 | 2024-10-22 |
| Clinical Study of Meningococcal ACYWX Conjugate Vaccine, in 12-16 Month Olds Non-adjuvanted study formulation NmCV-5, Adjuvanted study formulation NmCV-5, Menactra - Meningitis, Meningococcal | Phase 2 | Completed | Serum Institute of India Pvt. Ltd. | 375 | 2017-11-15 | 2025-05-25 |
Malaria (1) · Meningitis, Meningococcal (1)
Serum Institute of India Pvt. Ltd. (2) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
Mali (2) · India (1)
Dr Prasad Kulkarni, MD (1) · Patrick E Duffy, M.D. (1)